Cardinal Health, Inc.
$202.95
▼
-0.96%
2026-04-22 10:12:13
www.cardinalhealth.com
NYQ: CAH
Explore Cardinal Health, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$47.74 B
Current Price
$202.95
52W High / Low
$233.6 / $129.52
Stock P/E
29.15
Book Value
$-12.22
Dividend Yield
0.95%
ROCE
16.32%
ROE
-52.09%
Face Value
—
EPS
$6.95
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Distribution
Employees
53,084
Beta
0.65
Debt / Equity
-3.07
Current Ratio
0.91
Quick Ratio
0.5
Forward P/E
18.61
Price / Sales
0.21
Enterprise Value
$57.15 B
EV / EBITDA
14.95
EV / Revenue
0.23
Rating
Buy
Target Price
$248.27
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cosmos Health Inc. | $0.38 | — | $20.65 M | — | -53.42% | -63.82% | $1.32 / $0.28 | $0.73 |
| 2. | Accendra Health, Inc. | $3.52 | — | $270.97 M | — | 14.74% | -1.64% | $9.55 / $1.84 | $-6.04 |
| 3. | Synergy CHC Corp. | $0.51 | — | $5.93 M | — | -93.25% | 62.08% | $4 / $0.42 | $-0.73 |
| 4. | Empro Group Inc. | $17.36 | — | $144.63 M | — | 39.59% | 66.26% | $18.14 / $2.55 | $1.02 |
| 5. | Cencora, Inc. | $310.27 | — | $13.74 B | 0.73% | 20.96% | 1.33% | $377.54 / $271 | $9.81 |
| 6. | Henry Schein, Inc. | $78.73 | 24.1 | $9.06 B | — | 9.49% | 8.7% | $89.29 / $61.95 | $28.03 |
| 7. | McKesson Corporation | $837.14 | 24.1 | $102.52 B | 0.38% | 35.58% | -162.92% | $999 / $637 | $-10.55 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 65.63 B | 64.01 B | 60.16 B | 54.88 B | 55.26 B | — |
| Operating Profit | 763 M | 754 M | 585 M | 656 M | 530 M | — |
| Net Profit | 467 M | 450 M | 239 M | 506 M | 400 M | — |
| EPS in Rs | 1.98 | 1.91 | 1.02 | 2.15 | 1.7 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 222.58 B | 226.83 B | 204.98 B | 181.33 B |
| Operating Profit | 2.32 B | 2.13 B | 1.79 B | 1.65 B |
| Net Profit | 1.56 B | 852 M | 330 M | -938 M |
| EPS in Rs | 6.63 | 3.62 | 1.4 | -3.99 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 53.12 B | 45.12 B | 43.35 B | 43.88 B |
| Total Liabilities | 55.76 B | 48.33 B | 46.31 B | 44.58 B |
| Equity | -2.78 B | -3.21 B | -2.96 B | -709 M |
| Current Assets | 36.37 B | 34.88 B | 33.74 B | 32.94 B |
| Current Liabilities | 38.9 B | 35.64 B | 33.74 B | 30.55 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 2.4 B | 3.76 B | 2.84 B | 3.17 B |
| Investing CF | -5.59 B | -1.85 B | -454 M | 567 M |
| Financing CF | 1.94 B | -847 M | -3.05 B | -2.46 B |
| Free CF | 1.85 B | 3.25 B | 2.36 B | 2.79 B |
| Capex | -547 M | -511 M | -481 M | -387 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 10.66% | 13.04% | — | — |
| Earnings Growth % | 158.18% | 135.18% | — | — |
| Profit Margin % | 0.38% | 0.16% | -0.52% | — |
| Operating Margin % | 0.94% | 0.87% | 0.91% | — |
| Gross Margin % | 3.27% | 3.35% | 3.58% | — |
| EBITDA Margin % | 0.86% | 0.7% | 0.03% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-04-01 | $0.511 |
| 2026-01-02 | $0.511 |
| 2025-10-01 | $0.511 |
| 2025-07-01 | $0.511 |
| 2025-04-01 | $0.506 |
Stock Splits
No stock split history available.